Subtype-specific impacts of clonal hematopoiesis on the risk of cerebrovascular and cardiometabolic diseases - Takeaways - MDSpire

Subtype-specific impacts of clonal hematopoiesis on the risk of cerebrovascular and cardiometabolic diseases

  • By

  • Wenqiang Zhu

  • Miao Tian

  • Zihan Zhao

  • Xiaoquan Rao

  • April 28, 2026

  • 0 min

Share

  • 1

    Clonal hematopoiesis of indeterminate potential (CHIP) is linked to cerebrovascular and cardiometabolic diseases in aging populations.

  • 2

    TET2-CHIP shows the strongest associations with cerebrovascular outcomes, including ischemic stroke and hypertension.

  • 3

    Distinct CHIP subtypes exhibit marked heterogeneity in their effects on cerebrovascular and cardiovascular diseases.

  • 4

    JAK2-CHIP is inversely associated with intracerebral hemorrhage and atrial fibrillation, while DNMT3A-CHIP shows positive associations with atrial fibrillation.

  • 5

    The study highlights the need for subtype-specific risk assessment in understanding the clinical consequences of CHIP.

Original Source(s)

Subtype-specific impacts of clonal hematopoiesis on the risk of cerebrovascular and cardiometabolic diseases

  • by Wenqiang Zhu, Miao Tian, Zihan Zhao, Xiaoquan Rao

  • April 28, 2026

Related Content

Gastrogastric Intussusception 10 Years After Laparoscopic Gastric Greater Curvature Plication: a Case Report

A systematic review and meta-analysis of the effects of exercise training on dysfunction in acute, subacute, and chronic stroke patients

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management